Somite AI

United States - Boston, Massachusetts

• 14/05/2025
• Series A
• Undisclosed Amount

Somite.ai is developing AI foundation models for human stem cells to drive novel cell therapies at scale. We take a full-stack approach—generating data at 1,000x lower cost, training large-scale models with unmatched predictive power, and using these models to discover, refine, and optimize high-impact applications in cell therapy.

Our founding team includes repeat AI entrepreneur Dr. Micha Breakstone (Chorus.ai, acquired for $575M), the Head of the Fundamental AI Group at MIT (pioneered the foundational research on scaling laws), and four Harvard Medical School professors and National Academy of Sciences/Medicine members, including the Chair of the Genetics Department at HMS. Based in Boston and launching operations in January 2024, Somite has raised over $11M in pre-seed funding

Related People

Micha Y. Breakstone 🇮🇱🎗️Co Founder

United States - Austin, Texas

I’m a repeat entrepreneur who’s founded a few great businesses (e.g. chorus.ai), and am on a journey to make the world a slightly better place, one company at a time.

LinkedIn https://www.linkedin.com/in/michabreakstone/